Fast_RB ,_, Noninvasive_JJ Method_NN for_IN Molecular_NP Detection_NP and_CC Differentiation_NP of_IN Malassezia_NP Yeast_NP Species_NP on_IN Human_NP Skin_NP and_CC Application_NP of_IN the_DT Method_NN to_TO Dandruff_NP Microbiology_NP Malassezia_NP fungi_NNS have_VBP been_VBN the_DT suspected_JJ cause_NN of_IN dandruff_NN for_IN more_JJR than_IN a_DT century_NN ._SENT Previously_RB referred_VBN to_TO as_IN Pityrosporum_NP ovale_NP ,_, Pityrosporum_NP orbiculare_NN ,_, or_CC Malassezia_NP ,_, these_DT fungi_NNS are_VBP now_RB known_VBN to_TO consist_VB of_IN at_IN least_JJS seven_CD Malassezia_NP species_NNS ._SENT Each_DT species_NN has_VBZ a_DT specific_JJ ecological_JJ niche_NN ,_, as_RB well_RB as_IN specific_JJ biochemical_JJ and_CC genetic_JJ characteristics_NNS ._SENT Malassezia_NP yeasts_NNS have_VBP fastidious_JJ culture_NN conditions_NNS and_CC exceedingly_RB different_JJ growth_NN rates_NNS ._SENT Therefore_RB ,_, the_DT results_NNS of_IN surveys_NNS of_IN Malassezia_NP based_VBN on_IN culture_NN methods_NNS can_MD be_VB difficult_JJ to_TO interpret_VB ._SENT We_PP developed_VBD a_DT molecular_JJ technique_NN ,_, terminal_JJ fragment_NN length_NN polymorphism_NN analysis_NN ,_, to_TO more_RBR accurately_RB survey_VB the_DT ecology_NN of_IN Malassezia_NP yeasts_NNS without_IN bias_NN from_IN culture_NN ._SENT This_DT technique_NN involves_VBZ fluorescent_JJ nested_VBN PCR_NP of_IN the_DT intergenic_JJ transcribed_VBN spacer_NN (_( ITS_JJ )_) ITS_NNS I_PP and_CC ITS_NP II_NP region_NN ribosomal_JJ gene_NN clusters_NNS ._SENT All_DT known_JJ Malassezia_NP species_NNS can_MD be_VB differentiated_VBN by_IN unique_JJ ITS_JJ fragment_NN lengths_NNS ._SENT We_PP have_VBP used_VBN this_DT technique_NN to_TO directly_RB analyze_VB scalp_NN samples_NNS from_IN subjects_NNS enrolled_VBN in_IN a_DT demographic_JJ scalp_NN health_NN study_NN ._SENT Results_NNS for_IN subjects_NNS assigned_VBN composite_JJ adherent_JJ scalp_NN flaking_VBG scores_NNS (_( ASFS_NP )_) <10_were 24_CD ._SENT Malassezia_NP restricta_NP and_CC M._NP globosa_NP were_VBD found_VBN to_TO be_VB the_DT predominant_JJ Malassezia_NP species_NNS present_JJ in_IN both_DT groups_NNS ._SENT Importantly_RB ,_, we_PP found_VBD no_DT evidence_NN of_IN M._NP furfur_NN in_IN either_DT group_NN ,_, indicating_VBG that_IN M._NP furfur_NN can_MD be_VB eliminated_VBN as_IN the_DT causal_JJ organism_NN for_IN dandruff_NN ._SENT Both_DT groups_NNS also_RB showed_VBD the_DT presence_NN of_IN non-Malassezia_NN fungi_NNS ._SENT This_DT method_NN ,_, particularly_RB when_WRB it_PP is_VBZ used_VBN in_IN combination_NN with_IN existing_VBG fungal_JJ ITS_JJ databases_NNS ,_, is_VBZ expected_VBN to_TO be_VB useful_JJ in_IN the_DT diagnosis_NN of_IN multiple_JJ other_JJ fungal_JJ infections_NNS ._SENT Recently_RB ,_, members_NNS of_IN the_DT genus_NN Malassezia_NNS have_VBP become_VBN viewed_VBN as_IN opportunistic_JJ yeasts_NNS of_IN increasing_VBG importance_NN ._SENT They_PP are_VBP lipophilic_JJ or_CC lipid-dependent_JJ yeasts_NNS ,_, and_CC at_IN least_JJS some_DT belong_VBP to_TO the_DT normal_JJ cutaneous_JJ microflora_NN ._SENT Some_DT Malassezia_NP species_NN may_MD act_VB as_IN pathogens_NNS when_WRB exposed_VBN to_TO certain_JJ changes_NNS in_IN the_DT skin_NN microclimate_NN ._SENT For_IN decades_NNS the_DT genus_NN Malassezia_NP remained_VBD limited_JJ to_TO two_CD species_NNS ,_, namely_RB ,_, the_DT lipid-dependent_JJ Malassezia_NP furfur_NN and_CC the_DT lipophilic_JJ M._NP pachydermatis_NN ._SENT In_IN 1995_CD ,_, 28S_JJ rRNA_NN gene_NN sequences_NNS revealed_VBD seven_CD distinct_JJ genetic_JJ entities_NNS ,_, which_WDT are_VBP now_RB accepted_VBN as_IN species_NNS (_( M._NP furfur_NN ,_, M._NP obtusa_NP ,_, M._NP globosa_NP ,_, M._NP slooffiae_NNS ,_, M._NP sympodialis_NP ,_, M._NP pachydermatis_NN ,_, and_CC M._NP restricta_NP )_) ._SENT Malassezia_NN species_NNS are_VBP exceptionally_RB difficult_JJ to_TO cultivate_VB ,_, so_IN additional_JJ species_NNS may_MD be_VB discovered_VBN as_IN DNA-based_JJ differentiation_NN techniques_NNS are_VBP refined_VBN and_CC applied_VBN to_TO multiple_JJ ecosystems_NNS ._SENT While_IN several_JJ of_IN the_DT seven_CD described_VBD Malassezia_NP species_NNS have_VBP been_VBN associated_VBN with_IN human_JJ infection_NN ,_, the_DT pathological_JJ role_NN of_IN each_DT species_NN is_VBZ not_RB fully_RB understood_VBN ._SENT For_IN example_NN ,_, M._NP furfur_NN infections_NNS have_VBP been_VBN observed_VBN in_IN hospitalized_VBN neonates_NNS with_IN very_RB low_JJ birth_NN weights_NNS receiving_VBG intravenous_JJ lipid_NN emulsions_NNS ._SENT M._NP globosa_NP ,_, which_WDT corresponds_VBZ to_TO the_DT original_JJ description_NN of_IN Pityrosporum_NP orbiculare_NN and_CC correlates_VBZ to_TO the_DT former_JJ serovar_NN B_NN of_IN M._NP furfur_NN ,_, may_MD be_VB the_DT most_RBS important_JJ species_NNS in_IN pityriasis_NN versicolor_JJ ,_, either_CC alone_RB or_CC in_IN association_NN with_IN other_JJ species_NNS ,_, such_JJ as_IN M._NP sympodialis_NP ._SENT M._NP restricta_NP ,_, which_WDT corresponds_VBZ to_TO the_DT former_JJ serovar_NN C_NP of_IN M._NP furfur_NN and_CC which_WDT visually_RB resembles_VBZ Pityrosporum_NP ovale_NP ,_, is_VBZ the_DT species_NN most_RBS often_RB associated_VBN with_IN seborrheic_JJ dermatitis_NN and_CC dandruff_NN ._SENT M._NP pachydermatis_NP ,_, the_DT non-lipid-dependent_JJ species_NN ,_, is_VBZ rarely_RB observed_VBN in_IN humans_NNS but_CC has_VBZ been_VBN found_VBN to_TO cause_VB septic_JJ outbreaks_NNS ._SENT Understanding_VBG the_DT clinical_JJ role_NN of_IN the_DT individual_JJ species_NN has_VBZ been_VBN hampered_VBN by_IN the_DT difficulty_NN involved_VBN with_IN isolation_NN ,_, cultivation_NN ,_, and_CC identification_NN ._SENT Cultivation_NN requirements_NNS vary_VBP by_IN species_NNS ._SENT M._NP furfur_NN is_VBZ by_IN far_RB the_DT most_RBS robust_JJ of_IN the_DT Malassezia_NP species_NN in_IN culture_NN and_CC therefore_RB is_VBZ the_DT organism_NN most_RBS frequently_RB isolated_VBN ._SENT We_PP have_VBP found_VBN that_IN M._NP restricta_NP and_CC M._NP obtusa_NP are_VBP the_DT most_RBS difficult_JJ species_NNS to_TO grow_VB in_IN culture_NN ._SENT In_IN addition_NN to_TO specific_JJ nutrient_JJ requirements_NNS ,_, we_PP have_VBP also_RB found_VBN that_IN a_DT constant_JJ temperature_NN of_IN 34C_JJ is_VBZ required_VBN for_IN growth_NN of_IN M._NP restricta_NP ._SENT Both_DT M._NP globosa_NP and_CC M._NP restricta_NP grow_VB much_RB more_RBR slowly_RB than_IN M._NP furfur_NN in_IN culture_NN and_CC would_MD be_VB quickly_RB overwhelmed_VBN by_IN any_DT M._NP furfur_NN present_NN ,_, even_RB if_IN there_EX was_VBD initially_RB a_DT much_RB smaller_JJR number_NN of_IN M._NP furfur_NN cells_NNS present_JJ in_IN the_DT sample_NN ._SENT Several_JJ approaches_NNS have_VBP been_VBN used_VBN to_TO routinely_RB identify_VB Malassezia_NP species_NNS ._SENT These_DT include_VBP determination_NN of_IN the_DT mole_NN percent_NN guanine-plus-cytosine_NN content_NN ,_, DNA_NN reassociation_NN values_NNS ,_, cell_NN morphology_NN ,_, growth_NN with_IN different_JJ Tween_NP nonionic_JJ detergents_NNS as_IN the_DT sole_JJ lipid_NN supplement_NN ,_, the_DT presence_NN of_IN catalase_NN ,_, temperature_NN requirements_NNS ,_, the_DT presence_NN of_IN beta-glucosidase_NN revealed_VBN by_IN the_DT splitting_NN of_IN esculin_NN ,_, and_CC selective_JJ growth_NN with_IN cremophor_NN EL_NNS ._SENT In_IN addition_NN ,_, some_DT attempts_NNS have_VBP been_VBN made_VBN to_TO use_VB specific_JJ molecular_JJ methods_NNS for_IN the_DT identification_NN of_IN Malassezia_NP isolates_NNS ,_, such_JJ as_IN pulsed-field_JJ gel_NN electrophoresis_NN ,_, randomly_RB amplified_VBN polymorphic_JJ DNA_NN analysis_NN ,_, sequencing_VBG analysis_NN ,_, restriction_NN analysis_NN of_IN PCR_NP amplicons_NNS of_IN ribosomal_JJ sequences_NNS ,_, amplified_VBN fragment_NN length_NN polymorphism_NN analysis_NN ,_, and_CC denaturing_VBG gradient_JJ gel_NN electrophoresis_NN (_( -_: ,_, ,_, ,_, ,_, ,_, ;_: T._NP Boekhout_NP and_CC B._NP Theelen_NP ,_, abstract_JJ from_IN the_DT 20th_JJ International_NP Conference_NP on_IN Yeast_NP Genetics_NP and_CC Molecular_NP Biology_NP 2001_CD ,_, Yeast_NP 18:S332_NP ,_, 2001_CD )_) ._SENT While_IN these_DT approaches_NNS have_VBP met_VBN with_IN various_JJ degrees_NNS of_IN success_NN ,_, most_JJS are_VBP not_RB well_RB suited_VBN for_IN the_DT analysis_NN of_IN complex_JJ clinical_JJ samples_NNS ._SENT In_IN addition_NN ,_, all_RB of_IN the_DT methods_NNS mentioned_VBN above_IN (_( except_IN denaturing_VBG gradient_JJ gel_NN electrophoresis_NN )_) require_VBP cultivation_NN to_TO enhance_VB sensitivity_NN ,_, thereby_RB increasing_VBG both_CC the_DT potential_NN for_IN culture_NN bias_NN and_CC the_DT turnaround_NN time_NN for_IN analysis_NN ._SENT Two_CD methods_NNS have_VBP been_VBN reported_VBN to_TO differentiate_VB complex_JJ Malassezia_NP communities_NNS from_IN skin_NN without_IN cultivation_NN ,_, but_CC these_DT methods_NNS require_VBP either_DT separate_JJ amplification_NN with_IN specific_JJ primer_NN sets_NNS for_IN each_DT species_NN or_CC restriction_NN digestion_NN ._SENT The_DT terminal_JJ fragment_NN length_NN polymorphism_NN (_( tFLP_NN )_) method_NN uses_VBZ only_RB three_CD different_JJ primer_NN sets_NNS ,_, minimizing_VBG the_DT potential_JJ bias_NN related_VBN to_TO amplification_NN efficiency_NN ._SENT Because_IN it_PP has_VBZ been_VBN documented_VBN that_IN the_DT efficacies_NNS of_IN antifungal_JJ drugs_NNS can_MD vary_VB depending_VBG upon_IN the_DT species_NN ,_, timely_JJ clinical_JJ assessments_NNS are_VBP critical_JJ for_IN the_DT prompt_JJ administration_NN of_IN the_DT appropriate_JJ therapy_NN ,_, especially_RB when_WRB Malassezia_NP yeasts_NNS are_VBP responsible_JJ for_IN nosocomial_JJ bloodstream_NN infections_NNS ._SENT The_DT purpose_NN of_IN the_DT work_NN described_VBD here_RB was_VBD to_TO develop_VB a_DT specific_JJ and_CC highly_RB sensitive_JJ molecular_JJ method_NN suitable_JJ for_IN the_DT rapid_JJ and_CC reliable_JJ identification_NN of_IN Malassezia_NP species_NNS from_IN very_RB small_JJ clinical_JJ samples_NNS ._SENT A_DT key_JJ objective_NN was_VBD to_TO increase_VB the_DT sensitivity_NN of_IN the_DT method_NN to_TO eliminate_VB the_DT need_NN for_IN cultivation_NN and_CC thereby_RB increase_VB the_DT detection_NN rate_NN and_CC eliminate_VB cultural_JJ bias_NN in_IN the_DT results_NNS ._SENT Eliminating_VBG the_DT need_NN for_IN cultivation_NN and_CC restriction_NN digestion_NN would_MD also_RB significantly_RB reduce_VB the_DT turnaround_NN time_NN for_IN analysis_NN by_IN at_IN least_JJS 4_CD to_TO 5_CD days_NNS ,_, the_DT typical_JJ cultivation_NN time_NN selected_VBD ._SENT Preparation_NN of_IN standards_NNS and_CC clinical_JJ samples_NNS ._SENT |_SYM The_DT Malassezia_NP fungal_JJ strains_NNS used_VBN as_IN standards_NNS in_IN this_DT study_NN are_VBP listed_VBN in_IN Table_NP ._SENT These_DT strains_NNS were_VBD selected_VBN for_IN use_NN based_VBN on_IN the_DT following_VBG rationale_NN ._SENT First_RB ,_, two_CD isolates_NNS of_IN each_DT Malassezia_NP species_NN known_VBN to_TO have_VB been_VBN isolated_VBN from_IN human_JJ scalps_NNS were_VBD selected_VBN ._SENT Other_JJ common_JJ isolates_NNS of_IN phylogenetic_JJ importance_NN (_( based_VBN on_IN observation_NN of_IN multiple_JJ isolates_NNS in_IN the_DT laboratories_NNS of_IN the_DT Centraalbureau_NP voor_NP Schimmelcultures_NP [_SYM CBS_NP ]_SYM ,_, Utrecht_NP ,_, The_DT Netherlands_NPS )_) were_VBD included_VBN so_RB that_IN representative_JJ isolates_NNS of_IN the_DT major_JJ genotypic_JJ groups_NNS were_VBD considered_VBN ._SENT Standards_NNS were_VBD maintained_VBN on_IN Leeming_NP and_CC Notman_NP medium_NN (_( 1_CD %_NN [_SYM wt/vol_NN ]_SYM peptone_NN ,_, 0.5_CD %_NN [_SYM wt/vol_NN ]_SYM glucose_NN ,_, 0.01_CD %_NN [_SYM wt/vol_NN ]_SYM yeast_NN extract_NN ,_, 0.4_CD %_NN [_SYM wt/vol_NN ]_SYM desiccated_JJ ox_NN bile_NN ,_, 0.1_CD %_NN [_SYM vol/vol_NN ]_SYM glycerol_NN ,_, 0.05_CD %_NN [_SYM wt/vol_NN ]_SYM glycerol_NN monostearate_NNS ,_, 0.05_CD %_NN [_SYM vol/vol_NN ]_SYM Tween_NP 60_CD ,_, 1_CD %_NN [_SYM vol/vol_NN ]_SYM high-fat_JJ cow_NN 's_POS milk_NN ,_, and_CC 1.5_CD %_NN [_SYM wt/vol_NN ]_SYM agar_NN in_IN distilled_JJ water_NN )_) at_IN 30C_JJ (_( or_CC 34C_JJ for_IN M._NP restricta_NP )_) or_CC were_VBD stored_VBN at_IN -80C_NN ._SENT Stock_NN cultures_NNS were_VBD stored_VBN in_IN modified_JJ Dixon_NP liquid_JJ medium_NN (_( 3.6_CD %_NN [_SYM wt/vol_NN ]_SYM malt_NN extract_NN ,_, 0.6_CD %_NN [_SYM wt/vol_NN ]_SYM peptone_NN ,_, 2.0_CD %_NN [_SYM wt/vol_NN ]_SYM oxgall_NN ,_, 1.0_CD %_NN [_SYM vol/vol_NN ]_SYM Tween_NP 40_CD ,_, 0.2_CD %_NN [_SYM vol/vol_NN ]_SYM glycerol_NN ,_, and_CC 0.2_CD %_NN [_SYM vol/vol_NN ]_SYM oleic_JJ acid_NN in_IN distilled_JJ water_NN )_) with_IN 25_CD %_NN (_( wt/vol_NN )_) glycerol_NN at_IN -80C_NN ._SENT Standards_NNS cultures_NNS were_VBD supplied_VBN by_IN CBS_NP ._SENT Serial_JJ dilution_NN of_IN standards_NNS for_IN determination_NN of_IN sensitivity_NN were_VBD prepared_VBN by_IN counting_VBG the_DT cells_NNS on_IN a_DT Coulter_NP Counter_NP and_CC preparing_VBG dilutions_NNS of_IN known_VBN concentration_NN with_IN Dulbecco_NP 's_POS phosphate-buffered_JJ saline_NN (_( Invitrogen_NP Corp._NP ,_, Carlsbad_NP ,_, Calif._NP )_) ._SENT Concentrations_NNS are_VBP reported_VBN as_IN the_DT number_NN of_IN cells_NNS per_IN milliliter_NN of_IN dosing_VBG solution_NN ._SENT Swabs_NNS were_VBD prepared_VBN by_IN dosing_VBG 50_CD mul_NN of_IN the_DT counted_VBN cell_NN suspension_NN directly_RB onto_IN the_DT rayon_NN tip_NN ._SENT Extraction_NN ,_, sample_NN preparation_NN ,_, and_CC PCR_NP were_VBD then_RB carried_VBN out_RP in_IN the_DT same_JJ manner_NN used_VBN for_IN the_DT clinical_JJ samples_NNS ._SENT Samples_NNS were_VBD collected_VBN from_IN human_JJ subjects_NNS enrolled_VBN in_IN the_DT U.S._NP portion_NN of_IN a_DT demographic_JJ scalp_NN health_NN study_NN after_IN being_VBG graded_VBN for_IN scalp_NN flaking_VBG severity_NN ._SENT Scalp_NN flaking_VBG severity_NN was_VBD graded_VBN on_IN the_DT basis_NN of_IN the_DT adherent_JJ scalp_NN flaking_VBG scale_NN (_( ASFS_NP )_) ._SENT By_IN this_DT grading_VBG approach_NN ,_, an_DT expert_NN grader_NN ,_, who_WP was_VBD also_RB a_DT licensed_JJ dermatologist_NN in_IN this_DT case_NN ,_, assigned_VBN a_DT numerical_JJ grade_NN between_IN 0_CD and_CC 10_CD (_( with_IN 10_CD representing_VBG the_DT most_RBS flaking_VBG and_CC 0_CD representing_VBG the_DT least_JJS flaking_VBG )_) to_TO eight_CD divisions_NNS covering_VBG the_DT scalp_NN to_TO obtain_VB a_DT composite_JJ dandruff_NN score_NN ranging_VBG from_IN 0_CD to_TO 80_CD ._SENT Composite_NP ASFSs_NP of_IN less_JJR than_IN 10_CD can_MD be_VB considered_VBN normal_JJ scalps_NNS to_TO scalps_NNS with_IN low_JJ levels_NNS of_IN flaking_VBG ,_, whereas_IN composite_JJ scores_NNS of_IN greater_JJR than_IN 24_CD can_MD be_VB considered_VBN scalps_NNS with_IN high_JJ levels_NNS of_IN flaking_VBG associated_VBN with_IN severe_JJ dandruff_NN or_CC seborrheic_JJ dermatitis_NN ._SENT We_PP hereafter_RB use_VBP the_DT term_NN "_`` dandruff_NN "_'' in_IN this_DT report_NN to_TO include_VB subjects_NNS with_IN high_JJ levels_NNS of_IN flaking_VBG diagnosed_VBN with_IN dandruff_NN or_CC seborrheic_JJ dermatitis_NN ._SENT Samples_NNS from_IN human_JJ scalps_NNS were_VBD collected_VBN by_IN rubbing_VBG rayon_NN swabs_NNS (_( plain_JJ swab_NN ,_, sterile_JJ ;_: Copan_NP Diagnostics_NP ,_, Corona_NP ,_, Calif._NP )_) back_RB and_CC forth_RB over_IN a_DT 1-in_JJ stroke_NN area_NN for_IN 20_CD strokes_NNS while_IN continuously_RB rotating_VBG the_DT swab_NN ._SENT All_DT samples_NNS were_VBD collected_VBN from_IN human_JJ subjects_NNS in_IN accordance_NN with_IN federal_JJ guidelines_NNS and_CC institutional_JJ policies_NNS ._SENT Extraction_NN of_IN Malassezia_NP DNA_NP from_IN swabs_NNS ._SENT |_SYM The_DT DNA_NP extraction_NN procedure_NN described_VBD here_RB was_VBD optimized_VBN in_IN our_PP$ laboratory_NN for_IN the_DT extraction_NN of_IN Malassezia_NP DNA_NP ._SENT All_DT standard_NN ,_, sample_NN ,_, and_CC control_NN swabs_NNS were_VBD placed_VBN in_IN 15-ml_JJ conical_JJ tubes_NNS containing_VBG 0.6_CD ml_NN of_IN 0.01_CD %_NN sodium_NN dodecyl_NN sulfate_NN (_( diluted_VBN from_IN 10_CD %_NN sodium_NN dodecyl_NN sulfate_NN solution_NN [_SYM Invitrogen_NP Corp._NP ]_SYM with_IN distilled_JJ ,_, deionized_JJ water_NN )_) and_CC vortexed_JJ (_( Minivortexer_NP ;_: VWR_NP International_NP ,_, West_NP Chester_NP ,_, Pa._NP )_) at_IN medium_NN to_TO high_JJ speed_NN for_IN 20_CD s._NN The_DT swabs_NNS were_VBD removed_VBN from_IN the_DT tubes_NNS and_CC discarded_VBN ._SENT The_DT samples_NNS were_VBD then_RB transferred_VBN to_TO a_DT 1.5-ml_JJ screw-cap_NN tube_NN ._SENT One_CD half_NN of_IN the_DT tube_NN cone_NN was_VBD filled_VBN with_IN 0.5-mm_NP zirconia_NN and_CC silica_NN beads_NNS (_( Biospec_NP Products_NPS Inc._NP ,_, Bartlesville_NP ,_, Okla._NP )_) ,_, and_CC the_DT samples_NNS were_VBD beaten_VBN with_IN the_DT beads_NNS at_IN similar75_JJ %_NN maximum_NN speed_NN (_( Minibeadbeater-8_NP ;_: Biospec_NP Products_NPS )_) for_IN 10_CD s._NN The_DT samples_NNS were_VBD allowed_VBN to_TO cool_VB for_IN 10_CD s._NNS This_DT bead_NN beating_VBG and_CC cooling_VBG procedure_NN was_VBD repeated_VBN four_CD times_NNS for_IN a_DT total_NN of_IN five_CD times_NNS to_TO break_VB open_RP the_DT cell_NN walls_NNS ._SENT A_DT total_NN of_IN 400_CD mul_NN of_IN a_DT phenol-chloroform-isoamyl_NN alcohol_NN solution_NN (_( 25:24:1_CD [_SYM vol/vol/vol_NN ]_SYM ;_: Invitrogen_NP Corp._NP )_) was_VBD then_RB added_VBN ,_, and_CC the_DT mixture_NN was_VBD vortexed_VBN on_IN high_JJ for_IN 30_CD s_NNS ,_, followed_VBN by_IN centrifugation_NN (_( model_NN 5415C_NN ;_: Eppendorf_NP ,_, Hamburg_NP ,_, Germany_NP )_) at_IN 14,000_CD x_NN g_NN for_IN 10_CD min_NN ._SENT A_DT total_NN of_IN 350_CD mul_NN of_IN the_DT aqueous_JJ phase_NN was_VBD removed_VBN and_CC placed_VBN in_IN a_DT new_JJ tube_NN ._SENT To_TO this_DT extract_NN was_VBD added_VBN 35_CD mul_NN of_IN 3_CD N_NP sodium_NN acetate_NN (_( NaOAc_NP ;_: pH_NN 5.2_CD ;_: ISC_NP Bioexpress_NP ,_, Kaysville_NP ,_, Utah_NP )_) ._SENT The_DT mixture_NN was_VBD vortexed_VBN for_IN 2_CD s_NNS ,_, and_CC 0.5_CD mul_NN of_IN glycogen_NN (_( 20_CD mug/mul_NN ;_: Invitrogen_NP Corp._NP )_) and_CC 963.75_CD mul_NN of_IN ice-cold_JJ 100_CD %_NN ethanol_NN (_( EtOH_NP ;_: 200_CD proof_NN ;_: AAPER_NP Alcohol_NP ,_, Shelbyville_NP ,_, Ky._NP )_) were_VBD added_VBN ._SENT The_DT volumes_NNS of_IN NaOAc_NP and_CC EtOH_NP used_VBD were_VBD adjusted_VBN depending_VBG upon_IN the_DT actual_JJ amount_NN of_IN the_DT aqueous_JJ phase_NN recovered_VBN (_( for_IN NaOAc_NP ,_, 10_CD %_NN of_IN the_DT volume_NN recovered_VBD ;_: for_IN EtOH_NP ,_, 2.5_CD times_NNS the_DT total_JJ volume_NN of_IN the_DT aqueous_JJ phase_NN plus_IN NaOAc_NP and_CC glycogen_NN )_) ._SENT The_DT mixture_NN was_VBD then_RB vortexed_VBN for_IN 5_CD s_NNS and_CC stored_VBN at_IN -20C_NN for_IN 3_CD h_NN or_CC overnight_JJ ._SENT The_DT samples_NNS were_VBD then_RB precipitated_VBN by_IN centrifugation_NN at_IN 14,000_CD x_NN g_NN at_IN 4C_JJ for_IN 10_CD min_NN ._SENT The_DT supernatant_JJ was_VBD aspirated_VBN ,_, and_CC the_DT pellet_NN and_CC the_DT interior_NN of_IN the_DT tube_NN were_VBD washed_VBN by_IN addition_NN of_IN 1_CD ml_NN of_IN 70_CD %_NN ice-cold_JJ EtOH_NP (_( dilution_NN of_IN 200_CD proof_NN EtOH_NP in_IN distilled_JJ ,_, deionized_JJ H2O_NP ;_: AAPER_NP Alcohol_NP )_) ._SENT Centrifugation_NN and_CC aspiration_NN were_VBD repeated_VBN ,_, followed_VBN by_IN speed_NN vacuum_NN drying_VBG (_( model_NN SC110_NP ;_: Thermo_NP Savant_NP ,_, Holbrook_NP ,_, N.Y._NP )_) for_IN 5_CD min_NN at_IN a_DT medium_NN drying_VBG temperature_NN ._SENT The_DT pellet_NN was_VBD resuspended_VBN in_IN 20_CD mul_NN of_IN 1x_NP TE_NP (_( 1_CD mM_NP Tris-HCl_NP [_SYM 1_CD M_NN ;_: pH_NN 8_CD ;_: Sigma-Aldrich_NP Corporation_NP ,_, Sigma_NP ,_, St._NP Louis_NP ,_, Mo._NP ]_SYM ,_, 0.1_CD mM_NP EDTA_NP [_SYM 0.5_CD M_NN ;_: pH_NN 8_CD ;_: Invitrogen_NP Corp._NP ]_SYM )_) to_TO obtain_VB the_DT concentrated_JJ DNA_NN ._SENT All_DT samples_NNS were_VBD vortexed_VBN for_IN 5_CD s_NNS and_CC centrifuged_VBN at_IN 14,000_CD x_NN g_NN at_IN room_NN temperature_NN for_IN 5_CD s_NNS prior_RB to_TO storage_NN at_IN -20C_NN ._SENT Nested_VBN tFLP_JJ amplification_NN of_IN DNA_NP extracts_VBZ ._SENT |_SYM Three_CD sets_NNS of_IN primers_NNS were_VBD used_VBN in_IN this_DT work_NN ._SENT The_DT first_JJ set_NN of_IN primers_NNS (_( first_RB PCR_NP )_) consisted_VBD of_IN the_DT 18S_JJ forward_JJ primer_NN (_( 5'-AAC_NP TTA_NP AAG_NP GAA_NP TTG_NP ACG_NP GAA_NP G-3_NP '_'' )_) and_CC the_DT 28S_JJ reverse_NN primer_NN (_( 5'-GGC_NP AGG_NP AAC_NP CAG_NP CTA_NP CTA_NP G-3_NP '_'' )_) ._SENT The_DT second_JJ set_NN of_IN primers_NNS (_( ITS_NP I_NP PCR_NP )_) included_VBD the_DT ITS_NN I_PP forward_RB primer_JJR (_( 5'-TCC_NP GTA_NP GGT_NP GAA_NP CCT_NP GCG_NP G-3_NP '_'' )_) and_CC the_DT middle_JJ reverse_NN primer_NN (_( 5'-TTC_NP GCT_NP GCG_NP TTC_NP TTC_NP ATC_NP GA-3_NP '_'' )_) ._SENT The_DT third_JJ primer_NN set_VBN (_( ITS_NP II_NP PCR_NP )_) included_VBD the_DT middle_NN forward_RB primer_JJR (_( 5'-TCG_NP ATG_NP AAG_NP AAC_NP GCA_NP GCG_NP AA-3_NP '_'' )_) and_CC the_DT ITS_JJ II_NP reverse_NN primer_NN (_( 5'-TCC_NP TCC_NP GCT_NP TAT_NP TGA_NP TAT_NP GC-3_NP '_'' )_) ._SENT Two_CD primers_NNS were_VBD prepared_VBN and_CC fluorescently_RB labeled_VBD (_( the_DT ITS_NN I_PP forward_RB primer_JJR with_IN a_DT D3_NP label_NN and_CC the_DT ITS_NP II_NP reverse_JJ primer_NN with_IN a_DT D4_NP label_NN )_) by_IN Research_NP Genetics_NP ,_, Inc._NP (_( Huntsville_NP ,_, Ala._NP )_) for_IN subsequent_JJ fragment_NN analysis_NN ._SENT The_DT fluorescent_JJ dyes_NNS and_CC the_DT linkage_NN chemistry_NN are_VBP proprietary_JJ to_TO Beckman_NP and_CC are_VBP manufactured_VBN exclusively_RB by_IN Research_NP Genetics_NP ._SENT All_DT other_JJ primers_NNS were_VBD obtained_VBN from_IN Invitrogen_NP Corp._NP The_DT nested_VBN tFLP_NN amplification_NN scheme_NN is_VBZ shown_VBN in_IN Fig._NN ._SENT The_DT first_JJ step_NN of_IN the_DT nested_VBN PCR_NP process_NN involved_VBD amplification_NN of_IN parts_NNS of_IN all_DT three_CD ribosomal_JJ subunits_NN including_VBG the_DT variable_JJ regions_NNS ._SENT The_DT first_JJ set_NN of_IN PCR_NP primers_NNS (_( the_DT 18S_JJ forward_JJ and_CC 28S_JJ reverse_JJ primers_NNS )_) were_VBD selectively_RB designed_VBN to_TO span_VB the_DT 18S_JJ gene_NN through_IN the_DT 28S_JJ gene_NN (_( including_VBG both_CC the_DT internal_JJ transcribed_VBN space_NN [_SYM ITS_NP ]_SYM ITS_VBZ I_PP and_CC ITS_NP II_NP regions_NNS and_CC the_DT 5.8S_JJ gene_NN )_) of_IN fungal_JJ rRNA_NN gene_NN ._SENT The_DT primers_NNS were_VBD designed_VBN to_TO be_VB as_RB panfungal_JJ as_IN possible_JJ while_IN not_RB amplifying_VBG human_JJ or_CC bacterial_JJ DNA_NN ._SENT The_DT purpose_NN was_VBD to_TO increase_VB the_DT sensitivity_NN and_CC ,_, at_IN the_DT same_JJ time_NN ,_, to_TO minimize_VB background_NN interference_NN from_IN complex_JJ clinical_JJ samples_NNS ._SENT The_DT second_JJ two_CD sets_NNS of_IN PCR_NP primers_NNS were_VBD designed_VBN to_TO amplify_VB either_RB the_DT ITS_JJ I_CD region_NN (_( ITS_NP I_PP forward_RB and_CC middle_JJ reverse_JJ primers_NNS )_) or_CC the_DT ITS_JJ II_NP region_NN (_( middle_JJ forward_JJ and_CC ITS_JJ II_NP reverse_NN primers_NNS )_) ,_, in_IN which_WDT differences_NNS in_IN lengths_NNS among_IN Malassezia_NP species_NNS have_VBP been_VBN observed_VBN ._SENT The_DT ITS_NN I_PP forward_RB primer_JJR is_VBZ specific_JJ for_IN the_DT 3_CD '_POS region_NN of_IN the_DT 18S_JJ gene_NN ,_, and_CC the_DT ITS_JJ II_NP reverse_NN primer_NN is_VBZ specific_JJ for_IN the_DT 5_CD '_POS region_NN of_IN the_DT 28S_JJ gene_NN ._SENT The_DT middle_JJ forward_JJ and_CC middle_JJ reverse_JJ primers_NNS are_VBP complementary_JJ primers_NNS targeted_VBN to_TO the_DT 5.8S_JJ gene_NN ._SENT The_DT primer_NN locations_NNS result_NN in_IN fragments_NNS that_WDT contain_VBP some_DT ribosomal_JJ gene_NN sequences_NNS but_CC that_WDT are_VBP short_RB enough_RB for_IN accurate_JJ length_NN analysis_NN ._SENT The_DT second_JJ step_NN provides_VBZ additional_JJ amplification_NN to_TO increase_NN sensitivity_NN (_( eliminating_VBG the_DT need_NN for_IN prior_JJ cultivation_NN of_IN clinical_JJ samples_NNS )_) and_CC produces_VBZ two_CD fragments_NNS associated_VBN with_IN each_DT Malassezia_NP species_NN ._SENT Nested_VBN PCRs_NN ._SENT |_SYM The_DT PCR_NP conditions_NNS described_VBD below_IN were_VBD carried_VBN out_RP with_IN extracts_VBZ from_IN standards_NNS ,_, clinical_JJ samples_NNS ,_, and_CC controls_NNS ._SENT DNA_NP (_( 5_CD mul_NN )_) extracted_VBN from_IN each_DT sample_NN was_VBD added_VBN to_TO 45_CD mul_NN of_IN the_DT PCR_NP master_NN mixture_NN ,_, which_WDT consisted_VBD of_IN 5_CD mul_NN of_IN 10x_NP PCR_NP buffer_NN (_( Applied_NP Biosystems_NP Group_NP ,_, Applera_NP Corporation_NP ,_, Foster_NP City_NP ,_, Calif._NP )_) ,_, 3_CD mul_NN of_IN 25_CD mM_NP MgCl2_NP solution_NN (_( Applied_NP Biosystems_NP )_) ,_, 1_CD mul_NN of_IN a_DT 10_CD muM_NN deoxynucleotide_NN triphosphate_NN mixture_NN (_( 10_CD muM_NN each_DT dATP_NN ,_, dCTP_NN ,_, dGTP_NN ,_, and_CC dTTP_NNS [_SYM Invitrogen_NP Corp._NP ]_SYM diluted_VBN from_IN individual_JJ 100_CD mM_NP stocks_NNS combined_VBN into_IN deionized_JJ water_NN )_) ,_, 0.35_CD mul_NN of_IN each_DT primer_NN (_( 18S_JJ forward_JJ primer_NN [_SYM 0.5_CD mug/mul_NN ]_SYM and_CC 28S_JJ reverse_JJ primer_NN [_SYM 0.5_CD mug/mul_NN ]_SYM )_) ,_, 0.25_CD mul_NN of_IN Taq_NP DNA_NP polymerase_NN (_( 5_CD U/mul_NP ;_: Applied_NP Biosystems_NP )_) ,_, and_CC 35.05_CD mul_NN of_IN deionized_JJ water_NN ._SENT PCR_NP was_VBD performed_VBN in_IN a_DT thermocycler_NN (_( Touchdown_NP ;_: Thermo_NP Hybaid_NP ,_, Ashford_NP ,_, United_NP Kingdom_NP )_) with_IN an_DT initial_JJ denaturation_NN cycle_NN of_IN 5_CD min_NN at_IN 94C_NN ,_, 1_CD min_NN at_IN 60C_JJ ,_, and_CC 1_CD min_NN at_IN 72C_NP ,_, followed_VBN by_IN 18_CD cycles_NNS of_IN 1_CD min_NN at_IN 94C_NN ,_, 1_CD min_NN at_IN 60C_JJ ,_, and_CC 1_CD min_NN at_IN 72C_NP and_CC a_DT final_JJ extension_NN cycle_NN of_IN 1_CD min_NN at_IN 94C_NN ,_, 1_CD min_NN at_IN 60C_JJ ,_, and_CC 10_CD min_NN at_IN 72C_NP (_( for_IN a_DT total_NN of_IN 20_CD cycles_NNS )_) ._SENT In_IN the_DT two_CD nested_VBN PCRs_NNS ,_, 1_CD mul_NN of_IN the_DT first-round_JJ amplification_NN product_NN was_VBD added_VBN to_TO 49_CD mul_NN of_IN new_JJ reaction_NN mixtures_NNS consisting_VBG of_IN 5_CD mul_NN of_IN 10x_NP PCR_NP buffer_NN ,_, 5_CD mul_NN of_IN 25_CD mM_NP MgCl2_NP solution_NN ,_, 1_CD mul_NN of_IN a_DT 10_CD muM_NN deoxynucleotide_NN triphosphate_NN mixture_NN ,_, either_CC 1.38_CD mul_NN of_IN the_DT ITS_NN I_PP forward_RB primer_JJR (_( 20_CD muM_NN )_) and_CC 0.35_CD mul_NN of_IN the_DT middle_JJ reverse_NN primer_NN (_( 0.5_CD mug/mul_NN )_) or_CC 0.35_CD mul_NN of_IN the_DT middle_JJ forward_JJ primer_NN (_( 0.5_CD mug/mul_NN )_) and_CC 1.38_CD mul_NN of_IN the_DT ITS_JJ II_NP reverse_NN primer_NN (_( 20_CD muM_NN )_) ,_, 0.25_CD mul_NN of_IN Taq_NP DNA_NP polymerase_NN ,_, and_CC 36.02_CD mul_NN of_IN deionized_JJ water_NN ._SENT Both_DT PCR_NP amplifications_NNS were_VBD performed_VBN in_IN a_DT thermocycler_NN (_( Touchdown_NP ;_: Thermo_NP Hybaid_NP )_) with_IN an_DT initial_JJ denaturation_NN cycle_NN of_IN 5_CD min_NN at_IN 94C_NN ,_, 1_CD min_NN at_IN 50C_NN ,_, and_CC 1_CD min_NN at_IN 72C_NP ,_, followed_VBN by_IN 35_CD cycles_NNS of_IN 1_CD min_NN at_IN 94C_NN ,_, 1_CD min_NN at_IN 50C_NN ,_, and_CC 1_CD min_NN at_IN 72C_NP and_CC a_DT final_JJ extension_NN cycle_NN of_IN 1_CD min_NN at_IN 94C_NN ,_, 1_CD min_NN at_IN 50C_NN ,_, and_CC 10_CD min_NN at_IN 72C_NP (_( for_IN a_DT total_NN of_IN 37_CD cycles_NNS )_) ._SENT Fragment_NN analysis_NN ._SENT |_SYM Prior_RB to_TO fragment_VB analysis_NN ,_, 0.75_CD mul_NN of_IN the_DT ITS_NP I_NP PCR_NP product_NN and_CC 0.25_CD mul_NN of_IN the_DT ITS_NP II_NP PCR_NP product_NN were_VBD spiked_VBN with_IN 0.75_CD mul_NN of_IN an_DT internal_JJ base_NN pair_NN standard_NN (_( CEQ_NP DNA_NP size_NN standard_NN kit_NN 600_CD ;_: Beckman_NP Coulter_NP )_) in_IN a_DT 40-mul_JJ total_JJ volume_NN of_IN freshly_RB deionized_VBN formamide_NN (_( Mallinckrodt_NP Baker_NP ,_, Phillipsburg_NP ,_, N.J._NP )_) ._SENT The_DT internal_JJ base_NN pair_NN standard_NN includes_VBZ DNA_NN fragments_NNS ranging_VBG in_IN size_NN from_IN 60_CD to_TO 640_CD nucleotides_NNS ._SENT Fragment_NN analysis_NN was_VBD then_RB performed_VBN with_IN the_DT spiked_JJ sample_NN by_IN using_VBG a_DT fragment_NN analysis_NN instrument_NN (_( CEQ_NP 2000_CD XL_NP DNA_NP analysis_NN system_NN ;_: Beckman_NP Coulter_NP )_) ._SENT The_DT standard_JJ procedure_NN for_IN fragment_NN analysis_NN ,_, described_VBN in_IN the_DT manual_NN that_WDT accompanies_VBZ the_DT system_NN ,_, was_VBD followed_VBN ._SENT Species_NNS were_VBD identified_VBN by_IN size_NN analysis_NN of_IN two_CD unique_JJ fragments_NNS which_WDT contain_VBP the_DT complete_JJ ITS_NP I_CD region_NN (_( including_VBG some_DT 18S_JJ and_CC 5.8S_JJ gene_NN sequences_NNS )_) and_CC the_DT complete_JJ ITS_JJ II_NP region_NN (_( including_VBG some_DT 5.8S_JJ and_CC 28S_JJ gene_NN sequences_NNS )_) ._SENT According_VBG to_TO the_DT manufacturer_NN ,_, fragment_NN lengths_NNS are_VBP expected_VBN to_TO be_VB reproducible_JJ to_TO within_IN less_JJR than_IN +-0.27_JJ bp_NN units_NNS ,_, but_CC we_PP have_VBP found_VBN an_DT average_JJ reproducibility_NN of_IN +-1_JJ bp_NN to_TO be_VB more_RBR typical_JJ for_IN these_DT studies_NNS ._SENT Gel_NN electrophoresis_NN ._SENT |_SYM All_DT ITS_NN I_PP and_CC ITS_NP II_NP PCR_NP products_NNS were_VBD analyzed_VBN by_IN electrophoresis_NN in_IN a_DT 1.25_CD %_NN (_( wt/vol_NN )_) agarose_NN gel_NN by_IN standard_JJ procedures_NNS ,_, with_IN bands_NNS visualized_VBN by_IN staining_VBG with_IN SYBR_NP Green_NP stain_NN (_( SYBR_NP Green_NP I_NP Nucleic_NP Acid_NP Gel_NP stain_NN ;_: Molecular_NP Probes_NP ,_, Eugene_NP ,_, Oreg_NP ._SENT )_) ._SENT FIG._NN 1_CD ._SENT |_SYM Structure_NN of_IN ITS_JJ gene_NN region_NN and_CC locations_NNS of_IN primer_JJR sites_NNS ._SENT Structure_NN of_IN ITS_JJ gene_NN region_NN and_CC locations_NNS of_IN primer_JJR sites_NNS ._SENT TABLE_NN 1_CD |_SYM Malassezia_NP fungal_JJ species_NNS and_CC strains_NNS used_VBN as_IN standards_NNS and_CC fragment_NN length_NN obtained_VBN by_IN tFLP_NN analysis_NN Analysis_NN of_IN purified_VBN strains_NNS and_CC mixtures_NNS ._SENT |_SYM Examples_NNS of_IN typical_JJ fragment_NN analysis_NN results_NNS obtained_VBN for_IN standards_NNS and_CC mixtures_NNS of_IN standards_NNS are_VBP shown_VBN in_IN Fig._NN ._SENT Results_NNS obtained_VBN for_IN a_DT standard_JJ swab_NN inoculated_VBN with_IN a_DT pure_JJ M._NP restricta_NP (_( isolate_NN 7877_CD )_) culture_NN showed_VBD two_CD peaks_NNS ;_: one_PP represents_VBZ the_DT ITS_NN I_PP fragment_VBP (_( length_NN ,_, 294_CD bp_NN )_) and_CC another_DT represents_VBZ the_DT ITS_JJ II_NP fragment_NN (_( length_NN ,_, 460_CD bp_NN )_) ._SENT Note_NN that_IN the_DT label_NN at_IN 295.82_CD is_VBZ a_DT mislabeled_VBN shoulder_NN resulting_VBG from_IN the_DT high_JJ peak_NN at_IN 294_CD bp_NN ._SENT Base_JJ pair_NN standards_NNS were_VBD used_VBN as_IN internal_JJ controls_NNS by_IN the_DT fragment_NN analysis_NN software_NN to_TO calculate_VB and_CC assign_VB base_JJ pair_NN values_NNS to_TO standards_NNS and_CC unknowns_NNS ._SENT Fragment_NN analysis_NN results_NNS for_IN swabs_NNS dosed_VBN with_IN standard_JJ cultures_NNS are_VBP summarized_VBN in_IN Table_NP ._SENT In_IN addition_NN to_TO the_DT seven_CD Malassezia_NP species_NNS ,_, several_JJ isolates_NNS within_IN a_DT single_JJ species_NN resulted_VBN in_IN unique_JJ combinations_NNS of_IN fragment_NN lengths_NNS ._SENT This_DT indicated_VBD that_IN several_JJ genotypes_NNS could_MD be_VB distinguished_VBN within_IN one_CD species_NNS ._SENT For_IN example_NN ,_, all_DT three_CD M._NP globosa_NN isolate_NN standards_NNS (_( isolates_NNS 7874_CD ,_, 7966_CD ,_, and_CC 7990_LS )_) had_VBD unique_JJ fragment_NN patterns_NNS ._SENT Results_NNS obtained_VBN for_IN a_DT swab_NN inoculated_VBN with_IN a_DT mixture_NN of_IN all_DT seven_CD species_NNS (_( including_VBG 12_CD genotypes_NNS )_) of_IN Malassezia_NP showed_VBD 10_CD major_JJ ITS_NNS I_PP peaks_NNS and_CC 10_CD major_JJ ITS_JJ II_NP peaks_NNS associated_VBN with_IN the_DT seven_CD Malassezia_NP species_NNS ._SENT Assignments_NNS of_IN ITS_NP I_NP and_CC ITS_NP II_NP peaks_NNS on_IN the_DT basis_NN of_IN the_DT results_NNS for_IN the_DT standards_NNS were_VBD consistent_JJ with_IN all_DT 12_CD of_IN the_DT genotypes_NNS present_JJ in_IN the_DT mixture_NN :_: M._NP furfur_NN (_( isolate_NN 7982_CD )_) ,_, M._NP globosa_NP (_( isolate_NN 7966_CD )_) ,_, M._NP globosa_NP (_( isolate_NN 7874_CD )_) ,_, M._NP globosa_NP (_( isolate_NN 7990_CD )_) ,_, M._NP obtusa_NP (_( isolate_NN 7968_CD )_) ,_, M._NP restricta_NP (_( isolate_NN 7991_CD )_) ,_, M._NP restricta_NP (_( isolate_NN 7877_CD )_) ,_, M._NP restricta_NP (_( isolate_NN 8742_CD )_) ,_, M._NP slooffiae_NNS (_( isolate_NN 7971_CD )_) ,_, M._NP slooffiae_NNS (_( isolate_NN 7956_CD )_) ,_, M._NP sympodialis_NP (_( isolate_NN 7977_CD )_) ,_, and_CC M._NP pachydermatis_NP (_( isolate_NN ATCC_NP 74522_CD )_) ._SENT Although_IN 12_CD genotypes_NNS were_VBD used_VBN to_TO prepare_VB this_DT complex_JJ mixture_NN ,_, only_RB 10_CD ITS_NN I_CD peaks_NNS and_CC 10_CD ITS_JJ II_NP peaks_NNS were_VBD observed_VBN in_IN the_DT fragment_NN analysis_NN ._SENT This_DT is_VBZ because_IN there_EX is_VBZ some_DT overlap_VBP in_IN one_CD or_CC the_DT other_JJ fragment_NN length_NN value_NN ._SENT For_IN example_NN ,_, an_DT examination_NN of_IN M._NP restricta_NP shows_VBZ that_IN all_DT isolates_NNS tested_VBN have_VBP identical_JJ ITS_JJ II_NP peaks_NNS ,_, but_CC two_CD genotypes_NNS can_MD be_VB distinguished_VBN on_IN the_DT basis_NN of_IN differences_NNS in_IN ITS_NN I_PP fragment_VBP length_NN ._SENT Triplicate_JJ analysis_NN of_IN swabs_NNS inoculated_VBN with_IN the_DT same_JJ standard_JJ mixture_NN resulted_VBN in_IN ITS_NP I_NP and_CC ITS_NP II_NP peaks_NNS with_IN fragment_NN lengths_NNS that_WDT were_VBD reproducible_JJ within_IN +-1_JJ bp_NN ,_, but_CC with_IN various_JJ peak_NN heights_NNS ._SENT These_DT results_NNS demonstrate_VBP that_IN even_RB for_IN this_DT very_RB complex_JJ mixture_NN of_IN Malassezia_NP species_NNS ,_, the_DT nested_VBN tFLP_NN amplification_NN technique_NN ,_, followed_VBN by_IN fragment_NN analysis_NN ,_, is_VBZ capable_JJ of_IN separating_VBG and_CC identifying_VBG all_DT known_VBN species_NN ._SENT Evaluation_NN of_IN method_NN sensitivity_NN ._SENT |_SYM Gel_NP electrophoresis_NN analysis_NN was_VBD performed_VBN with_IN the_DT nested_VBN tFLP_JJ PCR_NP products_NNS from_IN serial_JJ dilutions_NNS of_IN each_DT Malassezia_NP standard_NN in_IN order_NN to_TO estimate_VB the_DT limit_NN of_IN detection_NN for_IN the_DT method_NN (_( see_VB Materials_NNS and_CC Methods_NNS )_) ._SENT The_DT results_NNS indicated_VBD that_IN the_DT detection_NN limit_NN for_IN each_DT Malassezia_NP standard_NN was_VBD on_IN the_DT order_NN of_IN 50_CD to_TO 100_CD cells/swab_NN ._SENT Analysis_NN of_IN human_JJ scalp_NN swab_NN specimens_NNS ._SENT |_SYM Fragment_NP analysis_NN of_IN a_DT representative_JJ human_JJ scalp_NN swab_NN specimen_NN showed_VBD two_CD distinct_JJ peaks_NNS associated_VBN with_IN ITS_NN I_PP fragments_VBZ and_CC two_CD peaks_NNS associated_VBN with_IN ITS_NP II_NP fragments_VBZ ,_, indicating_VBG the_DT presence_NN of_IN two_CD Malassezia_NP species_NNS ._SENT The_DT observation_NN of_IN ITS_NN I_PP fragment_VBP peaks_NNS at_IN base_JJ pair_NN values_NNS of_IN 294.87_CD and_CC 336.64_CD and_CC ITS_NP II_NP peaks_NNS at_IN base_JJ pair_NN values_NNS of_IN 460.40_CD and_CC 474.55_CD indicated_VBD the_DT presence_NN of_IN M._NP restricta_NP (_( isolate_NN 7877_CD or_CC 8747_CD or_CC both_CC )_) and_CC M._NP globosa_NP (_( isolate_NN 7966_CD )_) ,_, respectively_RB ._SENT These_DT results_NNS demonstrate_VBP that_IN the_DT amplification_NN achieved_VBN by_IN the_DT nested_VBN tFLP_NN approach_NN is_VBZ sufficient_JJ to_TO distinguish_VB Malassezia_NP fragments_NNS from_IN human_JJ scalp_NN swab_NN specimens_NNS ._SENT These_DT results_NNS also_RB show_VBP that_IN the_DT method_NN is_VBZ capable_JJ of_IN distinguishing_VBG three_CD different_JJ genotypes_NNS in_IN the_DT M._NP globosa_NN species_NNS and_CC two_CD different_JJ genotypes_NNS in_IN the_DT M._NP restricta_NN species_NNS ._SENT Samples_NNS isolated_VBN from_IN a_DT single_JJ human_JJ scalp_NN swab_NN specimen_NN and_CC analyzed_VBD in_IN triplicate_NN showed_VBD virtually_RB identical_JJ fragment_NN length_NN peaks_NNS (_( +-1_JJ bp_NN )_) ,_, but_CC the_DT peak_NN heights_NNS did_VBD vary_VB ._SENT Results_NNS for_IN human_JJ scalp_NN swab_NN specimens_NNS ._SENT |_SYM Results_NNS for_IN a_DT total_NN of_IN 70_CD subjects_NNS enrolled_VBN in_IN the_DT U.S._NP portion_NN of_IN a_DT scalp_NN health_NN study_NN are_VBP shown_VBN in_IN Fig._NN ._SENT A_DT total_NN of_IN 24_CD subjects_NNS were_VBD assigned_VBN composite_JJ ASFS_NNS of_IN less_JJR than_IN 10_CD and_CC 46_CD were_VBD assigned_VBN composite_JJ ASFS_NNS of_IN greater_JJR than_IN 24_CD by_IN an_DT expert_NN grader_NN ._SENT M._NP restricta_NP and_CC M._NP globosa_NP were_VBD the_DT predominant_JJ Malassezia_NP species_NNS found_VBD in_IN swab_NN specimens_NNS from_IN both_DT groups_NNS ._SENT However_RB ,_, subjects_NNS with_IN high_JJ composite_JJ ASFS_NNS were_VBD more_RBR likely_JJ to_TO show_VB the_DT presence_NN of_IN these_DT Malassezia_NP species_NNS (_( M._NP restricta_NP ,_, 72_CD %_NN with_IN a_DT high_JJ composite_JJ ASFS_NNS versus_IN 50_CD %_NN with_IN a_DT low_JJ composite_JJ ASFS_NNS ;_: M._NP globosa_NP ,_, 45_CD %_NN with_IN a_DT high_JJ composite_JJ ASFS_NNS versus_IN 33_CD %_NN with_IN a_DT low_JJ composite_JJ ASFS_NNS )_) ._SENT M._NP sympodialis_NNS was_VBD detected_VBN in_IN only_RB a_DT very_RB small_JJ percentage_NN of_IN both_DT groups_NNS (_( 8_CD %_NN with_IN a_DT low_JJ composite_JJ ASFS_NNS versus_IN 7_CD %_NN with_IN a_DT high_JJ composite_JJ ASFS_NNS )_) ._SENT M._NP slooffiae_NP and_CC M._NP obtusa_NP were_VBD observed_VBN only_RB in_IN a_DT very_RB small_JJ percentage_NN of_IN the_DT group_NN with_IN a_DT high_JJ composite_JJ ASFS_NNS (_( 4_CD and_CC 2_CD %_NN ,_, respectively_RB )_) ._SENT Importantly_RB ,_, there_EX was_VBD no_DT indication_NN of_IN the_DT presence_NN of_IN M._NP furfur_NN or_CC M._NP pachydermatis_NN in_IN scalp_NN swab_NN specimens_NNS from_IN any_DT subjects_NNS ._SENT A_DT significant_JJ percentage_NN of_IN subjects_NNS from_IN both_DT groups_NNS (_( 25_CD %_NN with_IN a_DT low_JJ composite_JJ ASFS_NNS versus_IN 28_CD %_NN with_IN a_DT high_JJ composite_JJ ASFS_NNS )_) showed_VBD the_DT presence_NN of_IN non-Malassezia_NP fungal_JJ species_NNS ._SENT Furthermore_RB ,_, scalp_NN swab_NN specimens_NNS from_IN subjects_NNS with_IN high_JJ composite_JJ ASFS_NNS were_VBD more_RBR likely_JJ to_TO have_VB detectable_JJ levels_NNS of_IN fungi_NNS than_IN those_DT assigned_VBN low_JJ composite_JJ ASFS_NNS (_( no_DT fungi_NNS were_VBD detected_VBN in_IN 15_CD %_NN of_IN those_DT with_IN a_DT high_JJ composite_JJ ASFS_NNS and_CC 29_CD %_NN of_IN those_DT with_IN a_DT low_JJ composite_JJ ASFS_NNS )_) ._SENT FIG._NN 2_CD ._SENT |_SYM Example_NN of_IN data_NNS obtained_VBN by_IN tFLP_NN analysis_NN ._SENT Example_NN of_IN data_NNS obtained_VBN by_IN tFLP_NN analysis_NN ._SENT (_( A_NP )_) Data_NP for_IN ITS_NP I_NP and_CC ITS_NP II_NP DNAs_NP isolated_VBD from_IN a_DT swab_NN inoculated_VBN with_IN a_DT pure_JJ M._NP restricta_NN culture_NN ;_: (_( B_NP )_) all_DT known_VBN genotypes_NNS of_IN Malassezia_NP inoculated_VBD onto_IN one_CD swab_NN ,_, showing_VBG that_IN all_DT species_NNS can_MD be_VB recovered_VBN when_WRB dosed_VBN in_IN equal_JJ proportions_NNS ._SENT Green_NP ,_, ITS_NP I_NP fragment_NN ;_: blue_JJ ,_, ITS_JJ II_NP fragment_NN ;_: red_JJ ,_, base_JJ pair_NN standards_NNS ._SENT FIG._NN 3_CD ._SENT |_SYM Example_NN of_IN data_NNS obtained_VBN by_IN tFLP_NN analysis_NN for_IN a_DT typical_JJ clinical_JJ swab_NN specimen_NN showing_VBG the_DT presence_NN of_IN M._NP globosa_NP Example_NN of_IN data_NNS obtained_VBN by_IN tFLP_NN analysis_NN for_IN a_DT typical_JJ clinical_JJ swab_NN specimen_NN showing_VBG the_DT presence_NN of_IN M._NP globosa_NP (_( isolate_NN 7966_CD )_) and_CC M._NP restricta_NP (_( isolate_NN 7877_CD or_CC 8747_CD or_CC both_CC )_) ._SENT FIG._NN 4_CD ._SENT |_SYM Frequencies_NNS of_IN species_NN detection_NN on_IN scalps_NNS of_IN subjects_NNS with_IN low_JJ and_CC high_JJ composite_JJ ASFSs_NP ._SENT Frequencies_NNS of_IN species_NN detection_NN on_IN scalps_NNS of_IN subjects_NNS with_IN low_JJ and_CC high_JJ composite_JJ ASFSs_NP ._SENT Malassezia_NP fungi_NNS have_VBP been_VBN the_DT suspected_JJ cause_NN of_IN dandruff_NN for_IN more_JJR than_IN a_DT century_NN ._SENT Identification_NN of_IN the_DT exact_JJ species_NN associated_VBN with_IN dandruff_NN has_VBZ been_VBN complicated_VBN by_IN several_JJ factors_NNS discussed_VBN previously_RB ,_, i.e._FW ,_, isolation_NN ,_, cultivation_NN requirements_NNS ,_, or_CC method_NN of_IN species_NN differentiation_NN ._SENT The_DT many_JJ nomenclature_NN changes_NNS ,_, from_IN Malassezia_NP to_TO Pityrosporum_NP ,_, and_CC the_DT recent_JJ identification_NN of_IN at_IN least_JJS seven_CD species_NNS in_IN the_DT genus_NN Malassezia_NNS have_VBP also_RB caused_VBN some_DT confusion_NN ._SENT In_IN early_JJ work_NN ,_, microscopic_JJ examination_NN of_IN specimens_NNS from_IN individuals_NNS with_IN dandruff_NN often_RB showed_VBD two_CD types_NNS of_IN fungi_NNS ._SENT They_PP were_VBD named_VBN P._NP ovale_NP and_CC P._NP orbiculare_NN on_IN the_DT basis_NN of_IN their_PP$ morphologies_NNS (_( bowling_NN pin_NN shaped_VBN and_CC round_NN ,_, respectively_RB )_) ._SENT Later_RBR ,_, the_DT original_JJ genus_NN name_NN Malassezia_NP was_VBD reinstated_VBN and_CC two_CD species_NNS were_VBD generally_RB accepted_VBN ,_, namely_RB ,_, the_DT lipid-dependent_JJ M._NP furfur_NN and_CC the_DT lipophilic_JJ M._NP pachydermatis_NN ._SENT The_DT two_CD entities_NNS associated_VBN with_IN dandruff_NN (_( P._NP ovale_NP and_CC P._NP orbiculare_NN )_) were_VBD grouped_VBN under_IN the_DT M._NP furfur_NN species_NNS as_IN serovar_NP C_NP and_CC serovar_NP B_NP ,_, respectively_RB ._SENT Recently_RB ,_, when_WRB seven_CD species_NNS were_VBD identified_VBN ,_, the_DT original_JJ M._NP furfur_NN designation_NN was_VBD further_RBR delineated_VBN into_IN six_CD species_NNS ._SENT Perhaps_RB due_JJ to_TO the_DT changes_NNS in_IN nomenclature_NN and_CC the_DT absence_NN of_IN reliable_JJ differentiation_NN methods_NNS ,_, recent_JJ dandruff_NN literature_NN continues_VBZ to_TO contain_VB references_NNS to_TO P._NP ovale_NP ,_, P._NP orbiculare_NN ,_, and_CC M._NP furfur_NN as_IN the_DT suspected_JJ causal_JJ agent_NN associated_VBN with_IN dandruff_NN ._SENT Here_RB we_PP report_VBP on_IN the_DT development_NN of_IN a_DT novel_JJ molecular_JJ technique_NN ,_, tFLP_NN analysis_NN ,_, for_IN the_DT rapid_JJ differentiation_NN of_IN Malassezia_NP species_NNS in_IN complex_JJ clinical_JJ samples_NNS ._SENT While_IN the_DT overall_JJ approach_NN is_VBZ based_VBN on_IN that_DT of_IN Liu_NP et_FW al._FW ,_, it_PP differs_VBZ in_IN that_DT restriction_NN analysis_NN is_VBZ not_RB required_VBN ._SENT Instead_RB ,_, this_DT method_NN involves_VBZ isolation_NN of_IN fungal_JJ DNA_NN ,_, followed_VBN by_IN nested_VBN PCR_NP of_IN the_DT ITS_NN I_PP and_CC ITS_NP II_NP regions_NNS of_IN the_DT ribosomal_JJ gene_NN cluster_NN with_IN fluorescent_JJ primers_NNS ,_, followed_VBN by_IN fragment_NN length_NN analysis_NN ._SENT Results_NNS obtained_VBN for_IN standards_NNS and_CC mixtures_NNS of_IN standards_NNS show_VBP that_IN all_DT known_JJ Malassezia_NP genotypes_NNS can_MD be_VB identified_VBN on_IN the_DT basis_NN of_IN unique_JJ fragment_NN lengths_NNS ,_, eliminating_VBG the_DT need_NN for_IN restriction_NN analysis_NN ._SENT Results_NNS from_IN this_DT study_NN also_RB show_VBP that_IN tFLP_NN analysis_NN is_VBZ capable_JJ of_IN reproducibly_RB assessing_VBG the_DT Malassezia_NP species_NN present_NN in_IN complex_JJ mixtures_NNS and_CC human_JJ scalp_NN samples_NNS ._SENT Importantly_RB ,_, it_PP is_VBZ specific_JJ for_IN fungi_NNS and_CC is_VBZ sufficiently_RB sensitive_JJ to_TO allow_VB direct_JJ assessments_NNS of_IN human_JJ scalp_NN swab_NN specimens_NNS without_IN the_DT need_NN for_IN prior_JJ cultivation_NN ._SENT Because_IN clinical_JJ assessments_NNS can_MD be_VB made_VBN without_IN prior_JJ cultivation_NN ,_, the_DT results_NNS are_VBP free_JJ from_IN culture_NN bias_NN and_CC the_DT turnaround_NN time_NN for_IN analysis_NN is_VBZ significantly_RB reduced_VBN ._SENT Specifically_RB ,_, we_PP have_VBP found_VBN that_IN a_DT single_JJ scalp_NN swab_NN specimen_NN can_MD be_VB analyzed_VBN within_IN 2_CD days_NNS of_IN receipt_NN ._SENT For_IN survey_NN work_NN ,_, the_DT sample_NN throughput_NN can_MD be_VB up_RB to_TO 75_CD samples_NNS per_IN week_NN ._SENT Overall_RB ,_, these_DT results_NNS show_VBP that_IN the_DT tFLP_NN approach_NN is_VBZ well_RB suited_VBN for_IN routine_JJ analysis_NN of_IN both_DT clinical_JJ samples_NNS and_CC ongoing_JJ screening_NN work_NN ._SENT The_DT tFLP_NN method_NN will_MD become_VB a_DT very_RB powerful_JJ tool_NN when_WRB used_VBN in_IN conjunction_NN with_IN the_DT new_JJ databases_NNS containing_VBG fungal_JJ ITS_JJ region_NN data_NNS that_WDT are_VBP becoming_VBG available_JJ ._SENT These_DT include_VBP databases_NNS by_IN Chen_NP et_FW al._FW and_CC by_IN Boekhout_NP et_FW al._FW ,_, which_WDT is_VBZ available_JJ on_IN CD-ROM_NP (_( Yeasts_NP of_IN the_DT World_NP 2.0_CD ,_, 2002_CD ,_, ETI_NP Biodiversity_NP Center_NP ,_, Amsterdam_NP ,_, The_DT Netherlands_NPS )_) ._SENT The_DT utility_NN of_IN the_DT tFLP_NN method_NN was_VBD evaluated_VBN by_IN analyzing_VBG scalp_NN swab_NN specimens_NNS from_IN subjects_NNS enrolled_VBN in_IN a_DT demographic_JJ scalp_NN health_NN study_NN ._SENT Samples_NNS were_VBD prepared_VBN by_IN extracting_VBG DNA_NN directly_RB from_IN scalp_NN swab_NN specimens_NNS ,_, without_IN prior_JJ cultivation_NN ._SENT Results_NNS for_IN subjects_NNS with_IN low_JJ composite_JJ ASFSs_NP (_( ASFS_NP ,_, <10)_were 24_CD )_) ._SENT In_IN general_NN ,_, the_DT overall_JJ fingerprint_NN of_IN Malassezia_NP species_NNS was_VBD found_VBN to_TO be_VB similar_JJ for_IN both_DT groups_NNS ,_, with_IN the_DT group_NN with_IN the_DT low_JJ composite_JJ ASFSs_NP typically_RB showing_VBG a_DT lower_JJR percentage_NN of_IN each_DT of_IN the_DT species_NN ._SENT The_DT most_RBS prevalent_JJ Malassezia_NP species_NNS found_VBD in_IN both_DT groups_NNS were_VBD M._NP restricta_NP and_CC M._NP globosa_NP ._SENT Only_RB the_DT group_NN with_IN high_JJ composite_JJ ASFSs_NP showed_VBD a_DT very_RB low_JJ incidence_NN of_IN M._NP slooffiae_NP and_CC M._NP obtusa_NP ._SENT Importantly_RB ,_, neither_DT group_NN showed_VBD the_DT presence_NN of_IN M._NP furfur_NN or_CC M._NP pachydermatis_NN ._SENT On_IN the_DT other_JJ hand_NN ,_, the_DT group_NN with_IN the_DT low_JJ composite_JJ ASFS_NNS had_VBD a_DT higher_JJR percentage_NN of_IN subjects_NNS in_IN whom_WP no_DT fungi_NNS were_VBD detected_VBN ._SENT In_IN addition_NN ,_, both_CC groups_NNS showed_VBD comparable_JJ levels_NNS of_IN non-Malassezia_NN fungi_NNS ._SENT The_DT identification_NN of_IN non-Malassezia_NP fungal_JJ species_NN in_IN the_DT present_JJ study_NN is_VBZ of_IN interest_NN ._SENT Cloning_VBG and_CC sequencing_VBG of_IN the_DT ITS_NN I_PP and_CC ITS_NP II_NP products_NNS are_VBP under_IN way_NN ._SENT It_PP is_VBZ not_RB surprising_JJ that_IN we_PP found_VBD no_DT indication_NN of_IN M._NP pachydermatis_NN in_IN these_DT human_JJ scalp_NN swab_NN samples_NNS because_IN this_DT species_NN is_VBZ typically_RB associated_VBN with_IN animals_NNS ._SENT However_RB ,_, the_DT absence_NN of_IN M._NP furfur_NN in_IN these_DT scalp_NN swab_NN samples_NNS has_VBZ important_JJ implications_NNS ._SENT While_IN we_PP cannot_MD draw_VB definitive_JJ conclusions_NNS regarding_VBG the_DT cause_NN of_IN dandruff_NN from_IN this_DT work_NN ,_, the_DT results_NNS strongly_RB indicate_VBP that_IN M._NP furfur_NN ,_, M._NP pachydermatis_NP ,_, M._NP slooffiae_NNS ,_, M._NP sympodialis_NP ,_, and_CC M._NP obtusa_NP can_MD be_VB eliminated_VBN as_IN potential_JJ causal_JJ organisms_NNS for_IN dandruff_NN ._SENT Several_JJ findings_NNS from_IN this_DT study_NN are_VBP consistent_JJ with_IN those_DT previously_RB reported_VBN by_IN Sugita_NP et_FW al._FW and_CC Gaitanis_NP et_FW al._FW ._SENT The_DT results_NNS of_IN these_DT studies_NNS are_VBP expected_VBN to_TO be_VB free_JJ of_IN potential_JJ culture_NN bias_NN ._SENT Importantly_RB ,_, Sugita_NP et_FW al._FW also_RB found_VBN evidence_NN for_IN both_DT M._NP restricta_NP and_CC M._NP globosa_NP in_IN a_DT high_JJ percentage_NN of_IN skin_NN swab_NN specimens_NNS obtained_VBN from_IN subjects_NNS judged_VBN to_TO be_VB healthy_JJ and_CC those_DT with_IN atopic_JJ dermatitis_NN (_( AD_NN )_) ._SENT Skin_NN samples_NNS from_IN patients_NNS judged_VBN to_TO be_VB healthy_JJ were_VBD also_RB more_RBR likely_JJ to_TO be_VB free_JJ of_IN detectable_JJ Malassezia_NP species_NNS than_IN samples_NNS from_IN subjects_NNS with_IN AD_NN ._SENT One_CD difference_NN between_IN these_DT two_CD studies_NNS is_VBZ the_DT higher_JJR frequency_NN of_IN M._NP sympodialis_NP and_CC M._NP furfur_NN detection_NN in_IN both_DT healthy_JJ subjects_NNS and_CC subjects_NNS with_IN AD_NN by_IN Sugita_NP et_FW al._FW ._SENT In_IN addition_NN ,_, the_DT study_NN of_IN Sugita_NP et_FW al._FW did_VBD not_RB detect_VB the_DT presence_NN of_IN non-Malassezia_NN fungi_NNS ._SENT The_DT former_JJ may_MD be_VB because_IN skin_NN samples_NNS were_VBD obtained_VBN from_IN a_DT variety_NN of_IN sites_NNS on_IN the_DT body_NN (_( scalps_NNS ,_, napes_NNS ,_, and_CC backs_NNS )_) ,_, whereas_IN the_DT samples_NNS evaluated_VBN in_IN the_DT present_JJ study_NN were_VBD obtained_VBN exclusively_RB from_IN the_DT scalp_NN ._SENT Furthermore_RB ,_, we_PP were_VBD able_JJ to_TO identify_VB non-Malassezia_NN fungal_JJ species_NN in_IN this_DT study_NN ,_, because_IN the_DT tFLP_NN approach_NN ,_, while_IN validated_VBN for_IN Malassezia_NP species_NNS in_IN our_PP$ laboratory_NN ,_, is_VBZ capable_JJ of_IN detecting_VBG other_JJ fungal_JJ species_NNS ._SENT The_DT method_NN used_VBN by_IN Sugita_NP et_FW al._FW makes_VBZ use_NN of_IN individual_JJ PCRs_NNS which_WDT are_VBP highly_RB selective_JJ for_IN individual_JJ Malassezia_NP species_NNS and_CC ,_, therefore_RB ,_, not_RB applicable_JJ for_IN screening_VBG of_IN other_JJ fungal_JJ species_NNS ._SENT The_DT only_JJ other_JJ study_NN ,_, to_TO our_PP$ knowledge_NN ,_, to_TO have_VB dealt_VBN with_IN detection_NN and_CC species_NN definition_NN of_IN Malassezia_NP has_VBZ been_VBN reported_VBN by_IN Gaitanis_NP et_FW al._FW ._SENT The_DT reported_VBN method_NN uses_VBZ PCR_NP followed_VBN by_IN restriction_NN fragment_NN length_NN polymorphism_NN (_( RFLP_NP )_) analysis_NN to_TO identify_VB the_DT species_NN present_NN in_IN skin_NN scales_NNS collected_VBN from_IN 17_CD sites_NNS ,_, including_VBG 5_CD on_IN the_DT human_JJ head_NN ,_, but_CC not_RB specifically_RB from_IN the_DT scalp_NN ._SENT Because_IN RFLP_NP analysis_NN requires_VBZ restriction_NN digestion_NN prior_RB to_TO analysis_NN ,_, there_EX would_MD be_VB a_DT loss_NN of_IN speed_NN and_CC method_NN sensitivity_NN (_( as_RB may_MD be_VB indicated_VBN by_IN the_DT detection_NN rate_NN of_IN 44_CD %_NN in_IN samples_NNS from_IN patients_NNS with_IN disease_NN compared_VBN to_TO a_DT detection_NN rate_NN of_IN 85_CD %_NN in_IN the_DT present_JJ study_NN )_) ._SENT Also_RB ,_, the_DT multiple_JJ banding_VBG pattern_NN resulting_VBG from_IN RFLP_NP analysis_NN complicate_VB 